Skip to content

    Navigation breadcrumbs

  1. Home
  2. Veterinary topics and resources
  3. All resources
  4. COVID-19 and animals

Library and information services

Access to electronic and print resources focused on veterinary science and animal health, plus services to support your study and keep up to date with clinical research.

Awards

Our awards celebrate achievements and build knowledge that contributes to evidence-based veterinary medicine.

History

We hold a unique collection of books, archives, artworks and artefacts which together offer an insight into the evolution of the British veterinary profession.

    Navigation breadcrumbs

  1. Home
  2. Veterinary topics and resources
  3. All resources
  4. COVID-19 and animals
Evidence collection2 July 2026

COVID-19 and animals

This evidence collection draws together resources and research on the impact of exposure to SARS-CoV-2 in animals and the impact of the COVID-19 pandemic on animal health and welfare.

Published 20 April 2020 | Updated 2 July 2026

Introduction

COVID-19 is the official designation of the human disease caused by the novel Coronavirus (SARS-CoV-2, Severe Acute Respiratory Syndrome Corona Virus 2) first identified in Wuhan China in December 2019 and leading to a pandemic from 2020–2023.

Although COVID-19 is a disease of people, with the virus being spread through direct (human to human) or indirect (human to surface to human) contact, concerns were raised that animals could be involved in COVID-19 in three main ways:

  1. they could be contaminated with live virus and act as fomites
  2. they could become infected with SARS-CoV-2 and develop signs of infection
  3. they could become infected and pass on the virus to other animals or humans.

Initial evidence about the impact of exposure to SARS-CoV-2 in animals and their role in the epidemiology of disease came from case reports of potentially infected animals, published in the media and on government websites and then reported in published literature. These reports led to experimental studies which looked at the susceptibility of different species to the virus and their potential role in transmission. Later epidemiological studies were published which reported on the prevalence of SARS-CoV-2 infection in different populations of animals. More recently review articles have been published bringing together a wider range of evidence on the role of animals on animal health and welfare.

Our first evidence collection on this subject included news reports and pre-prints as well as published evidence. We have recently reviewed the evidence collection and curated the references in a way that makes it easier to find the information you need.

This evidence collection provides a useful resource detailing the development of our knowledge of a novel disease and the importance of understanding the implications of diseases which can affect both humans and animals from a One Health perspective.

Part 1: Background information

References

Part 2: SARS-CoV-2 in animals

This section contains a curated collection of the published evidence relating to SARS-CoV-2 in animals. It includes published reports of animals that were naturally exposed or infected with SARS-CoV-2, providing useful information on the susceptibility and clinical signs. Also included are experimental studies reporting which animals can be experimentally infected with SARS-CoV-2 and transmit the virus to other animals under experimental conditions. This section also includes epidemiological studies into SARS-CoV-2 in different groups of animals. In interpreting and comparing the results of these studies is important to be clear about which population of animals was sampled, and which diagnostic tests were carried out. 

At the end of this section are links to a small number of references related to diagnostic testing for and vaccination against SARS-CoV-2 infection in animals.

Further details of reported cases of SARS-CoV-2 infection in animals can be found on the following websites:

2a. Review / multispecies

2b. Dogs and cats

Case studies

Experimental studies – including diagnostics and vaccination

Epidemiological studies

Non-domestic settings

By geographical location

2c. Hamsters

2d. Mustelids 

Domestic ferrets

Farmed mink

Feral mink

Wild mustelids

2e. Livestock

2f. Equine

2g. Other species

 SARS-CoV-2 infection has also been detected in a wide range of other species both in captivity and on the wild.

Large cats

Deer

Non-human primates

Bats

Other species

Part 3: Impact of the pandemic

The COVID pandemic had a significant impact on many aspects of life, including on animal ownership, the delivery of veterinary services and veterinary education. A number of articles and surveys have been published on the impact of the pandemic, which may provide information of interest and provide lessons for the future.

3a. One welfare

3b. Animal ownership

3c. Impact on animals / animal welfare

Behaviour

Health

Veterinary practice

3d. Veterinary education

About evidence collections

Evidence collections bring together collections of published papers on topics of interest and importance to the veterinary professions. Papers are chosen for relevance and accessibility, with the full text of articles either being available through the RCVS Knowledge library, on open access or from other publications to which a significant number of veterinary professionals are likely to have access. This means that there may be relevant evidence that is not included.

If you would like assistance in searching for further evidence on this topic you may find the following helpful EBVM Toolkit 2: Finding the best available evidence.

If you would like to suggest a paper for inclusion in one of our published evidence collections, or a topic for a future collection, please email library@rcvsknowledge.org

Next steps

Receive journal watch by email

Subscribe to have the latest summaries sent to your inbox

Claim CPD credit for your reading

Reading and reflecting on articles can count towards your CPD, and we have a template to help you with the process

Variant B.1.617.2 (Delta)